US SB1878 | 2015-2016 | 114th Congress
Status
Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on September 30 2016 - 100% progression
Action: 2016-09-30 - Became Public Law No: 114-229. (TXT | PDF)
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Bipartisan Bill
Status: Passed on September 30 2016 - 100% progression
Action: 2016-09-30 - Became Public Law No: 114-229. (TXT | PDF)
Text: Latest bill text (Enrolled) [PDF]
Summary
Advancing Hope Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers. The voucher program is extended by removing the provision terminating the program one year after the Food and Drug Administration's (FDA's) issuance of three rare pediatric disease vouchers. A voucher may not be issued for a rare pediatric disease product if a voucher was issued for the product as a tropical disease product. A drug sponsor that intends to request a voucher for a rare pediatric disease drug must notify the FDA of that intent upon submission of the new drug application.
Title
Advancing Hope Act of 2016
Sponsors
Sen. Robert Casey [D-PA] | Sen. Johnny Isakson [R-GA] | Sen. Sherrod Brown [D-OH] | Sen. Mark Kirk [R-IL] |
History
Date | Chamber | Action |
---|---|---|
2016-09-30 | House | Became Public Law No: 114-229. (TXT | PDF) |
2016-09-30 | House | Signed by President. |
2016-09-29 | House | Presented to President. |
2016-09-27 | House | Motion to reconsider laid on the table Agreed to without objection. |
2016-09-27 | House | On passage Passed without objection. (text: CR H5945-5946) |
2016-09-27 | House | Considered by unanimous consent. (consideration: CR H5945-5946) |
2016-09-27 | House | Committee on Energy and Commerce discharged. |
2016-09-27 | House | Mr. Walden asked unanimous consent to discharge from committee and consider. |
2016-09-22 | House | Referred to the House Committee on Energy and Commerce. |
2016-09-22 | House | Message on Senate action sent to the House. |
2016-09-22 | House | Received in the House. |
2016-09-22 | Senate | Passed Senate with an amendment by Unanimous Consent. |
2016-09-22 | Senate | The committee substitute as amended agreed to by Unanimous Consent. |
2016-09-22 | Senate | S.Amdt.5090 Amendment SA 5090 agreed to in Senate by Unanimous Consent. |
2016-09-22 | Senate | S.Amdt.5090 Amendment SA 5090 proposed by Senator Coats for Senator Sanders. |
2016-09-22 | Senate | Measure laid before Senate by unanimous consent. (consideration: CR S6062-6064) |
2016-04-05 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 415. |
2016-04-05 | Senate | Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report. |
2016-03-09 | Senate | Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. |
2015-07-28 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB1537 (Related) 2015-03-27 - Referred to the Subcommittee on Health.
Subjects
Blood and blood diseases
Cancer
Child health
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Hereditary and development disorders
Infectious and parasitic diseases
World health
Cancer
Child health
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Hereditary and development disorders
Infectious and parasitic diseases
World health